Manchegowda Pradeep, Singh Arun D, Shields Carol, Kaliki Swathi, Shah Parag, Gopal Lingam, Rishi Pukhraj
Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, India.
Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Ocul Oncol Pathol. 2021 Jun;7(3):159-167. doi: 10.1159/000512738. Epub 2021 Feb 9.
Despite limited data, some differences in the clinical profile can be observed in Asian population when compared with presentation of uveal melanoma (UM) in white population. The incidence of UM is higher in Whites than in Asians. For the purpose of comparison with Asian population, data from North America, Europe, and Australia were considered as that of "white" population. The annual incidence of UM has been reported to be 5-6 cases/million in whites. The incidence in different parts of Asia is estimated at 0.2-0.6 per million. The age of presentation is around 40-55 years in Asians, which is younger when compared to that of whites (mean age of 58 years). At presentation, mean basal diameter of tumors in Asians is greater compared to whites but overall, medium-size tumors are most common. Clinical presentation is straightforward in majority of cases with retinal detachment, acute glaucoma, uveitis, cataract, or vitreous hemorrhage as common symptoms. Epithelioid cell-type variant carries the worst prognosis. Management options for choroidal melanoma include transpupillary thermotherapy, plaque radiotherapy, charged particle irradiation, local resection, enucleation, or orbital exenteration. Most commonly used modalities are enucleation and plaque radiotherapy.
尽管数据有限,但与白人葡萄膜黑色素瘤(UM)的表现相比,亚洲人群在临床特征上仍可观察到一些差异。UM在白人中的发病率高于亚洲人。为了与亚洲人群进行比较,来自北美、欧洲和澳大利亚的数据被视为“白人”人群的数据。据报道,白人中UM的年发病率为每百万人口5 - 6例。亚洲不同地区的发病率估计为每百万人口0.2 - 0.6例。亚洲人的发病年龄在40 - 55岁左右,比白人(平均年龄58岁)要年轻。就诊时,亚洲人肿瘤的平均基底直径比白人更大,但总体而言,中等大小的肿瘤最为常见。大多数病例的临床表现较为直接,视网膜脱离、急性青光眼、葡萄膜炎、白内障或玻璃体出血是常见症状。上皮样细胞型变体的预后最差。脉络膜黑色素瘤的治疗选择包括经瞳孔温热疗法、敷贴放射疗法、带电粒子照射、局部切除、眼球摘除或眶内容剜除术。最常用的方法是眼球摘除和敷贴放射疗法。